Crowdbyte
AboutSign In

Zepbound

Product

Eli Lilly's injectable tirzepatide brand for weight management

3 stories

01
health1d ago

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

9 min read
02
health14d ago

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

9 min read
03
business24d ago

Hims & Hers Stock Surges Amid Weight-Loss Drug Battle with Novo Nordisk

9 min read
Crowdbyte

Every story, written for you.

Platform

TopicsPricing

Company

About

Legal

Terms of ServicePrivacy Policy
© 2026 Crowdbyte. All rights reserved.